The Ranibizumab Plus Transpupillary Thermotherapy for Neovascular Age-Related Macular Degeneration (AMD) Study
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00599222 |
|
Recruitment Status :
Completed
First Posted : January 23, 2008
Last Update Posted : November 22, 2011
|
Sponsor:
Anders Kvanta
Information provided by (Responsible Party):
Anders Kvanta, St. Erik Eye Hospital
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | November 2009 |
| Actual Study Completion Date : | February 2010 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):